Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07415681 · ClinicalTrials.gov registry record · Phase 2
GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Not yet
- Registry status
- Phase 2
- Development phase
- 116
- Enrollment target
NCT07415681 is a Phase 2 study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 116 participants.
The verdict
NCT07415681, a Phase 2 study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 116 participants
- Enrollment target
Study Summary
The purpose of study is to compare the side effects of two different forms of radiation for endometrial and cervical cancer. If you decide to enroll in this study, you will be randomized to one of two treatment groups. This study will compare two standard of care treatments: "Conventional" pHoton radiation versus pRoton radiation.
Interventions
- RADIATION Intensity Modulated Proton Therapy (IMPT)
- RADIATION Volume Modulated Arc Therapy (VMAT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2026-03 |
| Est. Completion | 2033-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07415681
The ClinicalTrials.gov registry entry for NCT07415681 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intensity Modulated Proton Therapy (IMPT) is the first listed.
NCT07415681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07415681 about?
NCT07415681 is a clinical study titled "GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries". The purpose of study is to compare the side effects of two different forms of radiation for endometrial and cervical cancer. If you decide to enroll in this study, you will be randomized to one of two treatment groups. This study will compare two standard of care treatments: "Conventional" pHoton ra...
What is the current status of trial NCT07415681?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2026-03. Estimated completion is 2033-12.
What interventions are being tested in trial NCT07415681?
The interventions under investigation include: Intensity Modulated Proton Therapy (IMPT) (RADIATION), Volume Modulated Arc Therapy (VMAT) (RADIATION).
Who is sponsoring clinical trial NCT07415681?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.